Questions about a clinical trial?

If you are a patient or a health care provider and would like more information about a clinical trial, please contact our research team.

Reach a BeiGene clinical trial representative

Search Clinical Trials

For a more refined search, use the

  • Age
  • Available Documents
  • Patient Level Data Anonymized patient level data for select studies available to qualified scientific researchers
  • Phases <strong>Phase 1:</strong> A step in clinical research to focus on the safety of a drug and how it works in the body. <strong>Phase 2:</strong> A step in clinical research to gather data on whether a drug works in people who have a certain condition or disease. <strong>Phase 3:</strong> A step in clinical research that gathers more information about a drug’s safety and if it works in people. <strong>Phase 4:</strong> A step in clinical research after regulatory authorities have approved a drug for marketing. <strong>N/A:</strong> For observational studies or interventional studies that do not support drug development.
  • Results
  • Sex In this context, a person’s sex refers to that person’s assigned sex at birth. This has been the case historically; however, there is growing understanding in the healthcare community that this definition excludes certain segments of the population and should be expanded, where possible, to account for gender identity as well. BeiGene recognizes the importance of making clinical trials accessible to all groups of people and is committed to promoting inclusive research.
  • Study Status <strong>Recruiting:</strong> The study is open to enrollment for qualified participants. <strong>Will be Recruiting:</strong> The study has not yet opened enrollment for qualified participants. <strong>Recruitment Complete:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but new potential participants are not currently being recruited or enrolled. <strong>Completed:</strong> The study has ended normally, and participants are no longer receiving an intervention or being examined. <strong>Other:</strong> All other study statuses such as withdrawn, canceled, or terminated.
  • Study Type <strong>Expanded Access:</strong> A way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by regulatory authorities. Also called compassionate use. <strong>Interventional:</strong> A type of clinical trial in which participants are assigned to groups that receive one or more treatment or study drug (intervention). <strong>Observational:</strong> A type of clinical study in which participants may receive diagnostic or study drugs but the study investigator does not assign participants to a a specific intervention or treatment.
  • Vaccine Studies
Clear

Search Results

Study ID
Phase
Condition(s)
Status
Sex
Age Range

BGB-16673-102

1

B-cell Malignancy, Low-grade | Non-Hodgkin Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Waldenström Macroglobulinemia

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-16673-102

Recruiting

Phase

1

Condition

B-cell Malignancy, Low-grade | Non-Hodgkin Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Waldenström Macroglobulinemia

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-101

1/2

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-101

Recruiting

Phase

1/2

Condition

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-214

2

Colorectal Cancer

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-214

Recruiting

Phase

2

Condition

Colorectal Cancer

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-308

3

Relapsed/Refractory Marginal Zone Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-308

Recruiting

Phase

3

Condition

Relapsed/Refractory Marginal Zone Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-23339-101

1

Not Determined

Recruiting

All

18 Years to 55 Years   (Adult)

Learn More

BGB-23339-101

Recruiting

Phase

1

Condition

Not Determined

Sex

All

Age

18 Years to 55 Years   (Adult)

Learn More

BGB-3111-218

2

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-218

Recruiting

Phase

2

Condition

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-212

2

Advanced Solid Tumor

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-212

Recruiting

Phase

2

Condition

Advanced Solid Tumor

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-205

2

Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC) | Nonsmall Cell Lung Cancer, Stage IV

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-205

Recruiting

Phase

2

Condition

Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC) | Nonsmall Cell Lung Cancer, Stage IV

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-16673-101

1

B-cell Malignancy | Marginal Zone Lymphoma | Follicular Lymphoma | Non-hodgkin Lymphoma | Waldenström Macroglobulinemia

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-16673-101

Recruiting

Phase

1

Condition

B-cell Malignancy | Marginal Zone Lymphoma | Follicular Lymphoma | Non-hodgkin Lymphoma | Waldenström Macroglobulinemia

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-213

2

Resectable Esophageal Squamous Cell Carcinoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-213

Recruiting

Phase

2

Condition

Resectable Esophageal Squamous Cell Carcinoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)

Learn More